Navigation Links
South Florida Dermatologists Win Over Golf Fans With Sun Safety Outreach at LPGA Playoffs

WEST PALM BEACH, Fla., Dec. 8 /PRNewswire/ -- In a region saturated with sunshine, South Florida physicians won the attention of appreciative golf enthusiasts at the recent ADT Championship LPGA Playoffs in West Palm Beach with free skin cancer screenings and sun safety education presented by the Women's Dermatologic Society (WDS). Local dermatologists conducted skin examinations for 249 spectators, LPGA Tour caddies and members of the media, with 36% of individuals screened referred for further diagnosis or biopsy of suspicious sites on the skin.


Led by board-certified Florida dermatologists De Anne Collier, MD (Jupiter) and Marta Rendon, MD (Boca Raton), a team of local dermatologists volunteered for a busy weekend of screenings, sun damage assessments, and sun safety education for crowds of the sunbelt's golf lovers. This effort chalks up the year's fifth and final outreach event for the Women's Dermatologic Society's Play Safe in the Sun, the 3-year community service campaign presented in collaborative partnership with L'Oreal USA. Since the joint effort began in May 2008, 56 dermatologists have volunteered 300 hours of their time and have identified hundreds of likely skin cancers among the WDS tent visitors.

"We are extremely pleased with the number of people who were screened at the ADT Championship LPGA Playoffs. Sun safety and protection start with educating all people, especially those who spend a lot of time outdoors. L'Oreal USA is proud to partner with the WDS' Play Safe in the Sun campaign and to be a part of this important initiative," states Philippe Patsalides, General Manager, Active Cosmetics Division, L'Oreal USA.

Board-certified dermatologists who volunteered for the screenings include: Giovanna Ciocca, MD, De Anne Collier, MD (Co-chair), Lynora Curtis, MD, Dana Corpus Holl, MD, Shauna Kay Kranendonk, MD, Ricardo Mejia, MD, Marta Rendon, MD (Co-chair), Leonid Trost, MD, Jill Waibel, MD and Donna Ann Zeide, MD. Additional volunteer support was provided by: Marianna Blyumin, MD, Shawna Hardy, and Martha Viera, MD. Boston University medical students Cindy Bae and Lisa Nguyen conducted sun damage assessment surveys. Medicis representatives Matt Woodall and Todd Goldberg also assisted with the outreach.

Highlights from this event include:

-- Board-certified dermatologists conducted 249 skin cancer screenings for fans, LPGA Tour caddies and members of the media;

-- 36% of the individuals screened were referred for further diagnosis/biopsy of suspicious sites presumptively diagnosed as skin cancers;

-- Volunteers performed 196 sun damage assessments with the UV reflectance unit;

-- 12,000 samples of free broad-spectrum sunscreen were distributed to the public with reminders to "re-apply every nine holes";

-- West Palm Beach Mayor Lois Frankel supported the WDS initiative by proclaiming a citywide "Play Safe in the Sun" Day to help raise awareness of the importance of sun protection.

The 3-year outreach campaign is made possible through a generous grant from L'Oreal USA to the WDS Foundation. Product donations were provided by Garnier, Lancome and La Roche-Posay.

WDS members Adrienne Stewart, MD (Denver, CO) and Michel McDonald, MD (Nashville, TN) serve as co-chairs of the WDS Service Committee, leading the national Play Safe in the Sun campaign. The volunteer outreach draws from the organization's 1,600 members to heighten sun safety awareness and promote healthy skin practices among outdoor sports enthusiasts. For further information, please visit: or


The Women's Dermatologic Society supports the careers and professional development of women dermatologists. The mission of the Women's Dermatologic Society is to help women in dermatology achieve their greatest personal and professional potential by striving to foster, promote, and support women's issues in dermatology; identify, train, and recognize women leaders in dermatology; provide a forum for developing relationships and the exchange of ideas and research relevant to women's issues; and promote the highest possible standards of ethics, research, patient care and education, as well as public education.


L'Oreal USA, headquartered in New York City, is a wholly owned subsidiary of L'Oreal SA, one of the world's leading beauty companies. L'Oreal USA has Research and Development, Manufacturing and Distribution facilities across eight states in the U.S, including New York, New Jersey, Kentucky, Arkansas, Illinois, Ohio, Colorado and Texas. L'Oreal's impressive portfolio of brands includes Lancome, Giorgio Armani, Shu Uemura, L'Oreal Paris, Garnier, Vichy, La Roche-Posay, L'Oreal Professionel and Kerastase. The U.S. is the base for the product development, international marketing and advertising for L'Oreal's nine American brands: Maybelline New York, Soft-Sheen, Carson, Kiehl's Since 1851, Ralph Lauren Fragrances, Redken 5th Avenue NYC, Matrix, Mizani, SkinCeuticals and PureOlogy.

SOURCE Women's Dermatologic Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. DNC: South Carolina Rejecting Romneys Smooth Talk on Health Care
4. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
5. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
6. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
7. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
8. ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship
9. USAID Assistant Administrator Hess Travels to Southern Africa
10. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
11. Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: